CAP 7 NEOPLASIAS-PATOLOGÍA ESTRUCTURAL Y FUNCIONAL DE ROBBINS-RESUMEN-PODCAST

Neoplasms Overview

Introduction to Neoplasms

• Neoplasias and tumors are terms used interchangeably, referring to abnormal tissue masses with autonomous growth that exceeds normal tissue growth.

• Tumors arise from acquired mutations that provide a proliferative advantage, spreading clonally from an initial malignant cell.

Classification of Tumors

Benign vs Malignant Tumors

• Benign tumors grow locally, do not invade surrounding tissues, and do not metastasize; they are generally resectable with a favorable prognosis. Exceptions exist.

• Malignant tumors, or cancers, exhibit aggressive behavior by invading nearby tissues and have the capacity for metastasis (spreading to other body parts).

Components of Tumors

• Tumors consist of two main components:

• Tumor parenchyma: Clonal expansions of neoplastic cells.

• Stroma: Non-neoplastic tissue and blood vessels; excessive collagenous stroma is termed desmoplasia. This results in hard tumor appearances.

Nomenclature of Tumors

Benign Tumor Naming Conventions

• Benign mesenchymal tumors typically end with the suffix "-oma" (e.g., lipomas, fibromas). Epithelial benign tumors also use this suffix but are named based on origin and histological characteristics (e.g., adenomas).

Malignant Tumor Classifications

• Malignant tumors are classified into:

• Carcinomas: Derived from epithelial origins.

• Sarcomas: Derived from mesenchymal origins (e.g., leiomyosarcoma). Squamous cell carcinomas differ from adenocarcinomas based on glandular growth patterns.

Special Types of Tumors

Mixed Tumors and Teratomas

• Mixed tumors arise from germ cells differentiating into multiple cell types (e.g., salivary gland tumors).

• Teratomas contain various cell types derived from all three germ layers (ectoderm, mesoderm, endoderm) and can be found in ovaries/testes as either benign or malignant forms.

Non-Neoplastic Lesions

• Non-neoplastic lesions include:

• Choristomas: Ectopic remnants of untransformed tissue.

• Hamartomas: Disorganized masses of native tissue specific to an area.

Characteristics Differentiating Benign and Malignant Neoplasms

Clinical Behavior Assessment

• The classification between benign and malignant neoplasms is based on clinical behavior alongside morphological evaluation and molecular profiling.

• Key factors include:

• Degree of differentiation: How closely tumor cells resemble normal cells.

• Local invasion extent: How far the tumor invades surrounding tissues.

• Metastasis potential: Ability to spread to other body parts. Although malignant tumors usually grow faster than benign ones, some may exhibit slow growth rates.

Differentiation vs Anaplasia in Tumors

Understanding Differentiation

• Differentiation refers to how much tumor cells resemble their normal counterparts morphologically and functionally; well-differentiated tumors retain original tissue functions like hormone production or keratin synthesis.

Anaplasia Characteristics

• Anaplasia indicates a lack of differentiation seen in malignant tumors where cells lose normal characteristics; these may appear undifferentiated or poorly differentiated compared to benign counterparts which are typically well-differentiated.

Histological Features of Malignant Tumors

Key Histological Characteristics

• Important features include:

• Pleomorphism: Variation in shape/size among cells or nuclei.

Characteristics of Tumors and Neoplasias

Key Features of Tumors

• An increased nucleus to cytoplasm ratio is a notable feature in tumor cells, indicating abnormal cellular growth.

• Atypical mitosis, such as tripolar mitoses (referred to as the "Mercedes Benz sign"), signifies unusual cell division patterns.

• Giant cell tumors are characterized by polyploidy or multiple nuclei, which can indicate aggressive behavior.

• Ischemic necrosis occurs due to inadequate blood supply, leading to cell death within tumors.

Metaplasia vs. Dysplasia

• Metaplasia involves the transformation of one mature cell type into another due to chronic damage or irritation; for instance, smokers may develop squamous metaplasia in bronchioles.

• Dysplasia refers to disordered cell growth with loss of uniformity and altered architecture; it can be classified as mild, moderate, or severe and may precede cancer but does not always lead to malignancy.

• Complete dysplasia affecting the entire epithelial thickness is termed in situ carcinoma, representing a preinvasive neoplasia.

Local Invasion and Malignancy

• Benign tumors typically grow en masse with a connective tissue capsule that allows for easier surgical removal without damaging surrounding tissues.

• Malignant tumors invade adjacent tissues without well-defined capsules, complicating surgical treatment and necessitating wider margins for removal.

Understanding Metastasis

• Metastasis is defined as the spread of tumor cells to distant sites via lymphatic vessels, blood vessels, or body cavities—distinguishing malignant from benign tumors.

• Factors increasing metastasis likelihood include lack of differentiation, local invasion capability, rapid growth rates, and larger tumor sizes.

Routes of Cancer Spread

• Seeding involves dispersion of tumor cells in body cavities like peritoneum or pleura; an example includes ovarian carcinoma spreading transperitoneally.

• Lymphatic dissemination leads tumor cells through regional lymph nodes before reaching other body parts; this often results in enlarged lymph nodes due to proliferation or immune response.

• Hematogenous dissemination describes spread through blood vessels typical for sarcomas and some carcinomas; common metastatic sites include lungs and liver.

Epidemiology of Cancer

Importance of Epidemiological Studies

• Epidemiological studies help identify environmental factors along with racial and gender-based risk factors associated with cancer development.

Global Impact on Cancer Mortality

• Since 1990, developed countries have seen an 18.4% decrease in cancer mortality rates among men and 10.4% among women.

Geographic Variation in Cancer Incidence

• Lung, stomach, and liver cancers are prevalent among men in developing countries while breast, cervical, and lung cancers dominate among women. This variation underscores the role of preventable environmental factors.

Key Environmental Risk Factors

• Tobacco consumption is linked primarily to cancers such as those affecting the oropharynx and lungs; it accounts for about 90% of lung cancer deaths.

• Alcohol consumption increases risks for various cancers including hepatocellular carcinoma due to cirrhosis caused by alcohol abuse.

Understanding Cancer: Key Factors and Mechanisms

Factors Influencing Cancer Development

• Timing of Pregnancies and Carcinogens: Occupational and environmental carcinogens, including UV radiation, radon, and industrial chemicals, play a significant role in cancer risk.

• Age as a Risk Factor: Most cancer cases occur in individuals over 55 years. It is the leading cause of death for women aged 40-79 and men aged 60-79 due to accumulated mutations and decreased immune response.

• Chronic Inflammation: Chronic inflammation is a predisposing factor for cancer, promoting cell proliferation in environments rich in genotoxic reactive oxygen species.

• Precursor Lesions: Morphological changes like metaplasia or hyperplasia can increase the risk of malignant transformations; untreated benign tumors may develop into cancer.

• Immunodeficiency States: Immunodeficiencies, particularly those affecting T-lymphocyte immunity, heighten the risk of cancers induced by oncogenic viruses.

Genetic Predisposition and Environmental Interactions

• Genetic Mutations: While 95% of tumors are sporadic with no clear hereditary basis, germline mutations can elevate cancer risks related to tumor suppressor genes.

• Hereditary vs. Sporadic Tumors: A hereditary predisposition does not guarantee cancer development; multiple gene interactions with environmental factors are crucial.

Molecular Basis of Cancer

• Genetic Damage as Carcinogenesis Foundation: Non-lethal genetic damage forms the basis for carcinogenesis through inherited or acquired mutations from environmental exposure.

• Tumor Progression Dynamics: Tumors start monoclonal but become heterogeneous as they grow. The progression involves acquiring malignant traits such as invasion and immune evasion.

Key Genes Involved in Cancer

• Proto-oncogenes & Tumor Suppressor Genes: Proto-oncogenes promote growth; their mutation leads to uncontrolled growth. Conversely, tumor suppressor genes inhibit growth—mutations here contribute to cancer development.

• Apoptosis Regulation Genes: Evasion of programmed cell death (apoptosis), due to gene mutations that regulate this process, increases cancer risk significantly.

Epigenetics and Cancer Characteristics

• Role of Epigenetics: Changes like DNA methylation affect genetic transcription and can silence tumor suppressor genes, playing a critical role in tumor development.

Cellular Features Characterizing Cancer

1. Self-sufficiency in Growth Signals: Tumors generate their own growth signals without external stimuli.

2. Insensitivity to Growth Inhibitory Signals: Cancer cells ignore signals that typically inhibit growth.

3. Altered Cellular Metabolism (Warburg Effect): Cancer cells often rely on aerobic glycolysis rather than oxidative phosphorylation for energy production.

4. Evasion of Apoptosis & Sustained Angiogenesis: These characteristics ensure nutrient supply while allowing continued survival despite cellular stress.

5. Capacity for Invasion & Metastasis: This ability allows cancer cells to spread beyond their original site effectively.

Understanding the Molecular Basis of Cancer

Key Genes in Cancer

• The primary genes associated with cancer mutations are BRAF and PI3K, which play a significant role in activating growth signaling pathways across various cancer types.

Molecular Basis of Cancer

• The molecular basis involves both genetic alterations and an epigenetic basis that contribute to tumor development.

Underlying Genetic Damage

• Carcinogenesis results from non-lethal genetic damage, which can be inherited or acquired through spontaneous mutations or environmental exposure, affecting critical genes involved in cell growth and genomic stability.

Monoclonal Proliferation

• Tumors typically arise from a single genetically damaged progenitor cell, initially monoclonal but becoming genetically heterogeneous as they grow due to accumulated mutations.

Types of Affected Genes

• Key gene categories impacted include:

• Proto-oncogenes

• Tumor suppressor genes

• Apoptosis-regulating genes

• DNA repair genes

Multi-step Processes in Carcinogenesis

• Carcinogenesis is gradual; the accumulation of mutations drives tumor progression, leading to more aggressive tumors with resistance mechanisms against immune responses.

Driver vs. Passenger Mutations

• Driver mutations actively contribute to malignancy and are essential for tumor transformation, while passenger mutations do not influence malignant behavior directly.

Genomic Instability and Epigenetic Alterations

• Genomic instability arises from the loss of function in maintenance genes, promoting additional mutations that favor cancer development.

• Epigenetic changes such as DNA methylation modifications also play a crucial role in cancer progression.

Oncogenes and Growth Signals

• Oncogenes enable autonomous proliferation by encoding proteins that promote cell growth without external signals. Proto-oncogenes serve as their normal precursors.

Characteristics of Oncoproteins

• Oncoproteins resemble normal proto-oncogene products but lack regulatory controls, allowing independent production regardless of growth stimuli.

Signaling Pathway Components

• Activation of receptor tyrosine kinases stimulates intracellular pathways (e.g., MAP kinase cascade), leading to unregulated cell growth due to specific mutations.

Growth Factor Receptors and Transcription Factors

• Mutations in growth factor receptors can lead to continuous activation; examples include HER2 in breast cancers.

• Transcription factors like MYC are overexpressed in many tumors, driving cell division.

Cyclins and Cell Cycle Regulation

• Deregulation involving cyclins and CDKs is fundamental for malignant transformation, causing uncontrolled proliferation at key cell cycle transitions.

Tumor Suppressor Genes Role

• Tumor suppressor genes act as checkpoints preventing uncontrolled growth by protecting against genetic mutation accumulation.

Loss-of-function Mechanisms

Understanding Cancer Risk Factors and Genetic Mutations

The Role of RB Gene in Cancer

• Mutations in the RB gene significantly increase cancer risk, as it regulates cell proliferation and controls the cell cycle at G1 and S points to prevent uncontrolled growth.

• The E2F transcription factor becomes overly active due to RB mutations, allowing cells to progress through the cell cycle without sufficient growth signals.

• Oncogenic viruses like human papillomavirus can disrupt RB function, promoting continuous cell cycle progression.

TP53: The Guardian of the Genome

• TP53 is crucial for preventing the spread of genetically defective cells and responds primarily to DNA damage.

• Over 50% of cancers exhibit mutations in TP53, compromising cellular responses to genetic damage; germline mutations lead to higher risks of malignancies such as in Le Fraumeni syndrome.

• When DNA repair fails, P53 induces senescence or apoptosis; defective P53 leads to resistance against chemotherapy and radiation therapy.

APC Gene and Colon Neoplasia

• The APC gene regulates WNT signaling pathways that control cell proliferation; mutations cause continuous WNT signaling leading to uncontrolled growth.

• Loss of APC is linked with beta-catenin mutations contributing to malignant transformation; 70-80% of sporadic colon cancers show APC loss of heterozygosity (LOH).

CDKN2A and Other Tumor Suppressor Genes

• CDKN2A encodes proteins P16 and NK4A that inhibit cyclin-dependent kinases by blocking RB phosphorylation; also produces P14 ARF which inhibits MDM2, preserving P53 levels.

• Mutations in CDKN2A are found in bladder tumors, head/neck cancers, some leukemias, and are silenced by hypermethylation in cervical cancers.

TGF-beta Pathway Implications

• TGF-beta binding activates intracellular signals via SMAD proteins leading to expression of growth inhibitory genes like CDKs; mutations affecting TGF-beta receptors are common in various cancers including colon and stomach cancers.

PTEN Gene Functionality

• PTEN acts as a tumor suppressor within survival pathways related to PI3K signaling; germline mutations are associated with Cowden syndrome increasing risks for several types of cancer including breast and thyroid.

NF1 & NF2: Neurofibromatosis Genes

• NF1 encodes neurofibromin regulating RAS signaling; loss leads to active RAS accumulation causing continuous division. Germline mutations predispose individuals to neurofibromatosis type 1.

• NF2 encodes merlin involved in intercellular junction regulation; germline mutations result in bilateral acoustic nerve tumors while somatic mutations link with meningiomas.

WT1 Gene's Role in Kidney Cancer

• WT1 is associated with Wilms tumor (kidney cancer), particularly affecting children. It plays a critical role in renal differentiation where its loss alters urogenital development.

Additional Genetic Factors Influencing Cancer Risk

• The PTCH1 gene negatively regulates hedgehog signaling pathway activation; its mutation causes Gorlin syndrome increasing risks for basal cell carcinoma among others.

Conclusion on BHL Gene Impact

Understanding Key Genetic Factors in Cancer

Role of HIF1 Alpha and Related Genes

• HIF1 alpha is crucial for regulating hypoxia responses; mutations in BHL can elevate levels of H and F1 alpha, leading to increased cell proliferation and angiogenesis.

• Loss of function in serine, triazolo-2 kinase 11 causes Peutz-Jeghers syndrome, an autosomal dominant disorder linked to gastrointestinal polyps and heightened cancer risk.

The Warburg Effect Explained

• The Warburg effect describes how tumor cells favor glycolysis over oxidative phosphorylation for energy production, even with oxygen present.

• This metabolic shift allows tumor cells to generate more intermediates necessary for macromolecule synthesis (e.g., DNA, proteins), facilitating rapid proliferation.

• The PI3KETA pathway enhances glucose uptake and stimulates lipid/protein synthesis, while MIC regulates glycolytic enzymes and glutamine usage.

Autophagy's Dual Role in Cancer

• Autophagy enables cells to consume their own components during nutrient scarcity; altered autophagy helps tumor cells survive adverse conditions.

• Tumor cells may enter a dormant state via autophagy, evading treatment and destruction, complicating cancer management.

Evading Apoptosis: Mechanisms at Play

• Cancer involves not only oncogene activation but also apoptosis pathway alterations; BCL2 proteins inhibit apoptosis by preventing cytochrome C release from mitochondria.

• Overexpression of BCL2 prolongs tumor cell lifespan, allowing mutation accumulation that contributes to tumor progression.

Unlimited Replication Potential in Tumor Cells

• Cancer cells can replicate indefinitely due to mechanisms overcoming senescence (cell division limit) and mitotic crisis (telomere shortening).

• Reactivation of telomerase lengthens telomeres, enabling continued replication similar to stem cells' self-renewal capabilities.

The Concept of Cancer Stem Cells

Characteristics and Implications

• Cancer stem cells share properties with abnormal stem cells: self-renewal ability and generation of other tumor cells contribute to treatment resistance.

• These characteristics may lead to relapse post-treatment as conventional therapies often fail to eradicate cancer stem cells.

Angiogenesis: A Critical Process for Tumor Growth

Mechanisms Driving Angiogenesis

• Tumors require new blood vessels for nutrient supply and waste elimination; angiogenesis is essential for growth beyond 1 or 2 mm.

• Factors like insulin-like growth factor and platelet-derived growth factor drive angiogenesis; the balance between pro-and antiangiogenic factors influences this process.

Impact of Hypoxia on Angiogenesis

Metastasis and Its Mechanisms

Tumor Cell Migration and Extracellular Matrix Degradation

• Tumor cells dissociate from neighboring cells, degrade the extracellular matrix, and migrate towards other cells. This process is crucial for metastasis.

• Matrix metalloproteinases (MMPs), such as MMP9, play a significant role in degrading the extracellular matrix, facilitating tumor migration, and releasing growth factors stored within it.

Vascular Dissemination of Tumor Cells

• Tumor cells can enter the bloodstream in small aggregates, associating with platelets and leukocytes to evade immune responses. The location of metastasis is influenced by vascular drainage from the primary tumor and interactions with specific receptors on tumor cells.

Molecular Genetics of Metastasis

• Although only a small proportion of tumor cells spread metastatically, some tumors exhibit a high frequency of metastatic signature cells that enhance their spreading capability. Mutations in genes related to mitochondria also affect metastasis potential.

Role of Stroma in Metastasis

• The surrounding stroma significantly influences tumor progression by promoting vascularization and degradation of the extracellular matrix, which aids in tumor growth and dissemination while complicating treatment strategies aimed at combating metastasis.

Genomic Instability and DNA Repair Mechanisms

Importance of DNA Repair Pathways

• DNA repair pathways are essential not only for correcting errors during cell division but also for preventing mutations caused by environmental factors like chemicals or radiation. Dysfunctional DNA repair can lead to increased cancer risk through mutations in oncogenes or tumor suppressor genes.

Types of DNA Repair Mechanisms

• Mismatch Repair: Corrects errors during DNA replication; defects can cause microsatellite instability.

• Nucleotide Excision Repair: Focuses on repairing UV-induced damage like pyrimidine dimers.

• Homologous Recombination Repair: Repairs double-strand breaks; dysfunction linked to hereditary syndromes such as Fanconi anemia and ataxia-telangiectasia.

Cancer Syndromes Related to DNA Repair Defects

Examples of Genetic Disorders Linked to Cancer Risk

• Lynch Syndrome: Caused by defects in mismatch repair genes (MSH2, MLH1), leading to colorectal cancer due to mutation accumulation.

• Xeroderma Pigmentosum: Results from nucleotide excision repair gene defects causing heightened sensitivity to UV damage and increased skin cancer risk.

• Disorders like Bloom syndrome are characterized by hypersensitivity to radiation due to homologous recombination repair defects involving genes such as ATM or BRCA1/BRCA2, increasing breast and ovarian cancer risks.

Neoplastic Mutations and Chromosomal Changes

Genetic Rearrangements Leading to Cancer

• During genetic rearrangement in lymphocytes, mutations may arise that promote lymphoid neoplasias; these occur during adaptive immunity's genetic recombination processes. Chromosomal alterations like translocations can activate oncogenes or create hybrid genes that drive cancer development (e.g., chromothripsis).

Epigenetic Changes Impacting Cancer Development

• Epigenetic modifications such as DNA methylation play critical roles in cancer progression alongside chromosomal changes that activate oncogenes or deactivate tumor suppressors through catastrophic rearrangements known as chromothripsis.

Carcinogenic Agents Influencing Cellular Interactions

Types of Carcinogens

• Carcinogens include chemical substances inducing mutations directly within cellular molecules; ionizing radiation causes direct DNA damage leading to mutations; oncogenic viruses (e.g., human papillomavirus) contribute significantly to cancer development through various mechanisms including integration into host genomes which disrupt normal cellular functions.

Understanding Chemical Carcinogenesis

Stages of Chemical Carcinogenesis

• The process of carcinogenesis is induced by chemicals and divided into two phases: initiation and promotion.

Phase 1: Initiation

• In the initiation phase, carcinogens induce irreversible mutations in the cellular genome. These agents are typically electrophiles that react with DNA, RNA, or proteins, causing non-lethal damage that cannot be repaired.

• Cells initiated in this phase do not exhibit autonomous growth or unique phenotypic characteristics but can generate tumors when stimulated by promoters.

Phase 2: Promotion

• During the promotion phase, previously initiated cells experience accelerated proliferation due to promoting substances. This phase is reversible and does not involve direct DNA damage.

• Promoters themselves are not tumorigenic but enhance the proliferation of mutated cells.

Types of Carcinogenic Agents

Direct vs. Indirect Acting Agents

• Direct-acting agents cause cancer without requiring metabolic conversion (e.g., alkylating agents used in chemotherapy).

• Indirect-acting agents require metabolic conversion via enzymes like P450 (e.g., polycyclic hydrocarbons).

Molecular Targets of Chemical Carcinogens

• Chemical carcinogens primarily interact with DNA, inducing mutations in critical genes such as oncogenes and tumor suppressor genes.

• Specific target sequences in DNA allow for identification of cancer-causing agents through mutation analysis.

The Role of Radiation in Carcinogenesis

Types of Radiation

Ultraviolet Radiation

• Ultraviolet radiation (280–320 nm), primarily from sunlight, is associated with skin cancers like carcinomas and melanomas, especially in fair-skinned individuals.

• It causes DNA damage through pyrimidine dimers; inadequate repair mechanisms can lead to cancer development.

Ionizing Radiation

• Ionizing radiation includes X-rays and particles (alpha, beta, neutrons), generating free radicals that damage DNA.

• Common radiation-induced cancers include myeloid leukemia and thyroid cancer in children.

Microbial Carcinogenesis: The Role of Viruses

Oncogenic RNA Viruses

• HTLV-I is a retrovirus linked to leukemia and T-cell lymphoma; it transmits through bodily fluids and targets CD4+ T cells.

Oncogenic DNA Viruses

Human Papillomavirus (HPV)

• High-risk HPV types (e.g., HPV16, HPV18) are closely associated with cervical cancer by disrupting viral DNA in host cells.

Epstein-Barr Virus (EBV)

• EBV infects B lymphocytes leading to their immortalization; LMP1 proteins activate pathways promoting B cell survival.

Cancer Development Factors

Hotkin's Lymphoma and Carcinogenesis Mechanisms

Hotkin's Lymphomas and Associated Tumors

• Hotkin's lymphoma is a subgroup associated with BEP, which includes rare lymphomas of T lymphocytes and NK lymphocytes.

• Nasopharyngeal carcinomas, particularly endemic in southern China, often contain the BEP genome, with LMP1 proteins playing a role in tumor development.

Viral Infections and Liver Cancer

• Hepatitis B virus (HBV) and hepatitis C virus (HCV) are linked to 70%-85% of hepatocellular carcinomas globally.

• Chronic inflammation from these infections is a key factor in carcinogenesis, leading to hepatocyte injury and mutagenic mediators.

Role of HBV in Carcinogenesis

• The HBV encodes a protein called HBX that can inactivate the P53 tumor suppressor gene while activating proto-oncogenes, promoting liver cancer.

Helicobacter Pylori and Gastric Carcinoma

• Helicobacter pylori infection can lead to gastric carcinoma through chronic inflammation; only 3% of infected individuals develop this condition.

• Specific strains like those expressing cytotoxin-associated gene A (CAGA) promote uncontrolled cell proliferation linked to gastric adenocarcinoma.

Cancer Cachexia and Paraneoplastic Syndromes

Understanding Cancer Cachexia

• Cancer cachexia involves significant loss of body fat, muscle mass, and weakness due to cytokines like TNF produced by inflammatory cells responding to tumors.

• Symptoms include appetite loss, metabolic changes reducing fat storage, and increased catabolism via the ubiquitin-proteasome pathway.

Common Paraneoplastic Syndromes

• Endocrinopathies occur when non-endocrine tumors produce hormones or hormone-like factors; for example, Cushing syndrome from small cell lung carcinoma ACT secretion.

• Hypercalcemia is frequently caused by bone resorption due to PTH-like peptides but not considered paraneoplastic if due to bone metastasis.

Grading and Staging of Tumors

Importance of Grading

• Grading assesses tumor differentiation; higher-grade tumors are less differentiated and tend to be more malignant than lower-grade ones.

Staging Systems

Diagnostic Methods in Oncology

Histological and Cytological Techniques

• The laboratory diagnosis relies on histological, cytological, molecular, and imaging methods alongside physical examinations. Emphasis is placed on the importance of histological methods.

• Histological studies involve analyzing tissue sections that are fixed in formalin or paraffin, as well as frozen sections for rapid diagnoses. Complete clinical information is crucial for accurate results.

• Cytological studies focus on individual cells; while false positives are rare, false negatives can occur due to sampling errors. A biopsy is often needed to confirm cytological findings before treatment.

• Immunocytochemistry uses specific antibodies to detect cellular products or surface markers. This technique aids in diagnosing undifferentiated tumors and determining metastasis origins.

Advanced Diagnostic Techniques

• Flow cytometry quantitatively measures membrane antigens or DNA content in tumor cells, particularly useful for leukemias and lymphomas.

• Circulating tumor cells can be isolated using three-dimensional flow chambers with specific antibodies. This method primarily serves research but allows early diagnosis by evaluating metastasis.

• Molecular diagnostics include PCR (polymerase chain reaction), which differentiates between neoplastic and reactive proliferations in lymphocytic lesions.

Genetic Analysis and Tumor Markers

• In situ fluorescent hybridization (FISH) helps diagnose specific malignant neoplasias by detecting characteristic translocations. Spectral karyotyping analyzes chromosomes using fluorochromes for small translocations.

• Hereditary cancer predisposition is assessed through gene mutation analysis (e.g., BRCA1, BRCA2).

• Tumor markers are molecules produced by tumors detected in blood/fluids; they assist in screening and assessing therapeutic responses rather than serving as primary diagnostic tools.

Examples of Tumor Markers

• Prostate-specific antigen (PSA), associated with both malignant neoplasms and benign conditions like prostatic hypertrophy, exemplifies a common tumor marker used clinically.

• CA markers can indicate various cancers such as colon, pancreatic, stomach, and breast cancers but may also elevate due to non-neoplastic disorders.

• Alpha-fetoprotein (AFP), linked with liver/testicular germ cell tumors, can also rise in conditions like cirrhosis.